<DOC>
	<DOCNO>NCT02087826</DOCNO>
	<brief_summary>The purpose research study examine whether specific gene ( e.g . SLC16A11 ) affect human being respond food medication commonly use treat type 2 diabetes . The food investigator study specially prepared contain protein , carbohydrate , fat . The drug investigator study metformin . The investigator hypothesize physiological response meal medication differ carrier non-carriers gene associate type 2 diabetes .</brief_summary>
	<brief_title>Common Variation SLC16A11 Other Genes Response Mixed Meal Tolerance Test</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>Adult male nonpregnant female Age 1879 Able willing give consent relevant genetic investigation Women pregnant , nursing , risk become pregnant Currently take medication use treatment diabetes History liver disease and/or aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) 3 time upper limit normal ( ULN ) Estimated glomerular filtration rate ( eGFR ) &lt; 60 ml/min/1.73 m2 calculate Modification Diet Renal Disease equation Currently take intend take study duration medication know affect glycemic parameter , glucocorticoid , growth hormone , fluoroquinolones Contraindications safe use metformin , include plan radiologic angiographic study require contrast within one week study completion Planned change prescribe medication , specifically diuretic , study enrollment Participation interventional study study duration Conditions cause intestinal malabsorption , include celiac disease history intestinal gastric bypass surgery Dietary restriction would prevent consumption MMTT Objection inability take metformin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>